DG
14
-3
LEN
45
3
PLD
43
-2
SRE
47
2
FSLR
63
5
K
50
-3
AXP
69
2
PNC
53
-2
AIZ
66
-2
ISRG
68
-3
CHRW
51
-6
AVGO
88
27
STZ
54
2
KEY
31
2
CVX
23
-2
XRX
52
3
ADM
30
-3
DVA
63
-2
HUM
33
2
MCHP
43
6
DG
14
-3
LEN
45
3
PLD
43
-2
SRE
47
2
FSLR
63
5
K
50
-3
AXP
69
2
PNC
53
-2
AIZ
66
-2
ISRG
68
-3
CHRW
51
-6
AVGO
88
27
STZ
54
2
KEY
31
2
CVX
23
-2
XRX
52
3
ADM
30
-3
DVA
63
-2
HUM
33
2
MCHP
43
6
Financhill
Back

Cipher Pharmaceuticals 10K Form

Sell
40

CPHRF
Cipher Pharmaceuticals

Last Price:
10.01
Seasonality Move:
0.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPHRF News And Ratings

See the #1 stock for the next 7 days that we like better than CPHRF

CPHRF Financial Statistics

Sales & Book Value

Annual Sales: $21.16M
Cash Flow: $1.98M
Price / Cash Flow: 19.09
Annual Sales: $3.86
Price / Book: 2.59

Profitability

EPS (TTM): 0.63000
Net Income (TTM): $15.86M
Gross Margin: $17.09M
Return on Equity: 18.38%
Return on Assets: 15.34%

Cipher Pharmaceuticals Earnings Forecast

Key Cipher Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 17 years for CPHRF is 80.77%.
  • The Selling, General & Administrative Expenses for CPHRF have been equal to 25.48% of Gross Profit Margin.
  • The Research & Development expenses have been 2.08% of Revenue.
  • The Interest Expense is 1.16% of Operating Income.
  • The Net Earning history of CPHRF is 96.32% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Cipher Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CPHRF
Website: cipherpharma.com

Debt

Debt-to-Equity Ratio: 0.4
Current Ratio: 2
Quick Ratio: 1.57

Price-to-Earnings

Trailing P/E Ratio: 12.52
Forward P/E Ratio: 0

CPHRF Technical Analysis vs Fundamental Analysis

Sell
40
Cipher Pharmaceuticals (CPHRF) is a Sell

Is Cipher Pharmaceuticals a Buy or a Sell?